X

Pharmacometrics & Pharmacokinetics (PMK) Community

Community Goals

Scientific Expertise:
  • The PMK Community is a unique resource to learn about newer applications of pharmacometrics and pharmacokinetics and best practices via programming, webinars and white papers enabled by participation of members with diverse interests (pharmacokineticists, statistical pharmacometricians, PBPK experts, transporter experts from industry, academia, and regulatory, and student/trainees).
Catalyst for Innovation:
  • Hosts educational forums to promote emerging areas of influence by thought-leaders. Also contributes to establishing point-counterpoint formats to discuss hot topics to enhance the attendee experience at Annual Meetings.
Influence and Impact:
  • Currently working to identify at least one focus area for which a concept outline will be developed for a Best Practice White Paper followed by 2-year goal to publish an article.
Education and Communication:
  • The PMK Community is exploring opportunities to set up a model library to capture pertinent technical information to supplement information in published articles from select journals. PMK is also active on social media will ensuring frequent communication with members.
Organizational Effectiveness:
  • PMK has established Steering Committee membership along with general roles & expectations necessary to align with contributions with other Community goals. The Community is also developing a communication outreach plan to Community members to announce key dates and news updates.

Join the LinkedIn Group.


Upcoming Webinar
ASCPT Pharmacometrics & Pharmacokinetcs (PMK) Community Members-Only Webinar
Title:  Marrying Real-World Data and Modeling: A Case of Interdisciplinary MIDD to Address Changes of Bone Mineral Density in Premenopausal Women
Date and Time: Friday, August 14, 2020, 11:00 am ET
Speaker: Mohamad Shebley, PhD
Moderators: Chunze Li, PhD, and Akshanth Polepally, PhD
Description: This webinar will introduce the concept of interdisciplinary model-informed drug development (i-MIDD) in a real drug development setting. The presented work will describe how real-world data (RWD) could be linked to traditional pharmaco-statistical modeling to bridge understanding of long-term bone safety in premenopausal women. The work will highlight how the RWD could be extended to epidemiological modeling for evaluating clinical relevance of the projected changes in bone mineral density (BMD) in relation to future risk of bone fractures. For additional information, please click the registration link below.
Registration Link: 
https://us02web.zoom.us/webinar/register/WN_7eQ1iOZSQL6hQIHQSScsCg

Past Webinars

Chunze Li, PhD

Community Chair

 

N Gupta

Neeraj Gupta, PhD

Community Vice Chair

 

Sreeneeranj Kasichayanula, PhD

Community Past Chair

 

Steering Committee

Neeraj Gupta, PhD
Chao Liu, PhD
Robert Bies, PharmD, PhD
Hechun Wang, MS
Xiaoying Chen, PhD
Chunze Li, PhD
Michael Tortorici, PharmD, PhD
Photo Gallery
Recent News
Contact Us